Tao Wang

机构：Tianjin University of Traditional Chinese Medicine · ORCID：0000-0002-7978-0710

发表论文 198 篇 · 总被引 3941 次 · h-index 34

代表论文

• Intestinal FXR deficiency induces dysregulation of xanthine oxidase and accounts for sex difference in hyperuricemia (2024 · Free Radical Biology and Medicine · 被引 19)
• Mechanism of Biqi capsules in the treatment of gout based on network pharmacology and experimental verification (2024 · Journal of Ethnopharmacology · 被引 18)
• Anemoside B4 ameliorates dextran sulfate sodium (DSS)-induced colitis through inhibiting NLRP3 inflammasome and modulating gut microbiota (2023 · European Journal of Pharmacology · 被引 17)
• Astragaloside Ⅳ negatively regulates Gpr97-TPL2 signaling to protect against hyperhomocysteine-exacerbated sepsis associated acute kidney injury (2024 · Phytomedicine · 被引 16)
• Biodegradable Manganese-Containing Mesoporous Silica Nanoparticles for Precisely Controlled Quercetin Delivery (2024 · ACS Applied Nano Materials · 被引 12)
• Marine n-3 polyunsaturated fatty acids slow sleep impairment progression by regulating central circadian rhythms in type 2 diabetes (2025 · Cell Reports Medicine · 被引 8)